Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

BACKGROUND: Blood biomarkers of neuronal damage could facilitate clinical management of and therapeutic development for Huntington's disease. We investigated whether neurofilament light protein NfL (also known as NF-L) in blood is a potential prognostic marker of neurodegeneration in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Byrne, Lauren M, Rodrigues, Filipe B, Blennow, Kaj, Durr, Alexandra, Leavitt, Blair R, Roos, Raymund A C, Scahill, Rachael I, Tabrizi, Sarah J, Zetterberg, Henrik, Langbehn, Douglas, Wild, Edward J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507767/
https://www.ncbi.nlm.nih.gov/pubmed/28601473
http://dx.doi.org/10.1016/S1474-4422(17)30124-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507767/
https://www.ncbi.nlm.nih.gov/pubmed/28601473
http://dx.doi.org/10.1016/S1474-4422(17)30124-2

Ejemplares similares